CDSCO panel seeks justification for Pfizer Phase III CT of 20-Valent Pneumococcal Conjugate Vaccine
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok